BRIEF-Organovo’S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company
ReutersFeb 25, 2025 2:38 PM
Feb 25 (Reuters) - Eli Lilly and Co LLY.N:
- ORGANOVO’S FXR PROGRAM, INCLUDING FXR314, TO BE ACQUIRED BY ELI LILLY AND COMPANY
- ORGANOVO HOLDINGS INC - TO RECEIVE UPFRONT PAYMENT AND MILESTONES FOR FXR314
- ORGANOVO HOLDINGS INC - LILLY ACQUIRES ALL COMMERCIAL AND IP RIGHTS TO FXR PROGRAM
Source text: ID:nGNX2v9LqC
Further company coverage: LLY.N
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Google’s AI Reset: Why Q1 Could Trigger a Valuation Rerate
TradingKey - Alphabet’s Q1 2025 results make it official, that transition into an AI-first infrastructure platform is not theoretical anymore, it’s commercial. Irrespective of a crowded generative AI race and growing scrutiny of its market dominance, Alphabet’s stack of complete AI, monetized at scaTradingKey
12 hours ago
Tesla Q1 2025 Earning Report Review: Autonomous Driving and Robotics Lead Future Growth
TradingKey - Tesla's Q1 2025 earnings results revealed short-term financial pressure, with core data lower than market expectations, and both revenue and profitability facing challenges. Against the backdrop of sales and profit pressure, Musk remains confident in Tesla's future.TradingKey
Wed, Apr 23
Alphabet Inc. (GOOGL) Q1 2025 Earnings Preview: AI Innovations Amid Regulatory Scrutiny
TradingKey - Alphabet Inc. (GOOGL) is scheduled to post Q1 2025 results on April 24, 2025, after market close. Analysts see revenue of $89.22 billion, up 11% from the year ago period, and EPS of $2.01 versus $1.89 for the comparable period a year ago.TradingKey
Wed, Apr 23
